1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson’s Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Recent studies have revealed significant roles of neurotransmitters and gut microbiota along the gut-brain axis in Parkinson's disease (PD); however, the potential mechanisms remain poorly understood. In the current study, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced characteristic PD neurobehavior changes accompanied by increased α-synuclein, apoptotic protein Bim, and cleaved caspase-3 and decreased expression of tyrosine hydroxylase (TH). Meanwhile, the tryptophan (Trp) and tyrosine (Tyr) neurotransmitter metabolites involving kynurenine (KYN), serotonin (5-HT), and dopamine (DA) pathways were significantly changed in serum. Furthermore, the step-limited enzymes, which are responsible for the key metabolic pathways of these neurotransmitters, were obviously dysregulated. The 16S rRNA gene sequence results indicated that the abundance and diversity of the microbiota were obviously decreased in MPTP-treated mice, the presence of Ruminococcus, Parabacteroides and Parasutterella genera were obviously increased, while Coriobacteriaceae, Flavonifractor , Lachnospiraceae, Lactobacillaceae, and Rikenellaceae abundance was markedly decreased. The connectivity between the gut microbiota and neurotransmitter metabolism revealed that the gut microbiota dysbiosis was associated with disturbance of the DA, KYN, and 5-HT metabolic pathways. Therefore, our results provide evidence that gut-microbiota-brain axis disturbance may play an important role in PD development and ta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concerning PD, dysbiosis followed by GI symptoms and gut discomfort far precedes the onset of motor dysfunctions and it is linked to neuroinflammation, as well as to alterations in dopamine, serotonin, and kynurenine metabolism through the gut-brain axis [40,41,42,43,44,45,46]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [44]
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
The microbiome-gut-brain axis in health and disease
Dinan, T. G., & Cryan, J. F. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.007 · Cited by 1,111
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Henke, M. T., Kenny, D. J., Cassilly, C. D., Vlamakis, H., Xavier, R. J., & Clardy, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904099116 · Cited by 812
Cited by
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases
Sarkar, A., Yoo, J. Y., Valeria Ozorio Dutra, S., Morgan, K. H., & Groer, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030459 · Cited by 342
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Ren, Q., Cheng, L., Guo, F., Tao, S., Zhang, C., Ma, L., & Fu, P. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03449 · Cited by 77
dos Santos, J. C. C., Oliveira, L. F., Noleto, F. M., Gusmão, C. T. P., Brito, G. A. D. C., & Viana, G. S. D. B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373673 · Cited by 76
“, 2020) or subcutaneously (Lai et al., 2018; Zhu et al., 2020); rotenone administered orally (Bhattarai et al.”
BackgroundLayunta, E., Buey, B., Mesonero, J. E., & Latorre, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.748254 · Cited by 73
Benameur, T., Porro, C., Twfieg, M.-E., Benameur, N., Panaro, M. A., Filannino, F. M., & Hasan, A. (2023) · Brain Sciences · doi:10.3390/brainsci13081226 · Cited by 60
Zhang, W., Chen, S., Huang, X., Tong, H., Niu, H., & Lu, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01549-0 · Cited by 64
Oshaghi, M., Kourosh‐Arami, M., & Roozbehkia, M. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06413-0 · Cited by 62
Lee, Y. Z., Cheng, S.-H., Chang, M.-Y., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076794 · Cited by 63
Jiang, Z., Wang, X., Zhang, H., Yin, J., Zhao, P., Yin, Q., & Wang, Z. (2023) · MedComm · doi:10.1002/mco2.268 · Cited by 50
Self-citationGu, J., Zhu, Y., Guo, M., Yin, X., Liang, M., Lou, X., Chen, J., Zhou, L., Fan, D., Shi, L., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156221 · Cited by 47
Self-citationKulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-230206 · Cited by 40
Iwaniak, P., Owe-Larsson, M., & Urbańska, E. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052915 · Cited by 34
“Considering that chronic MPTP administration increases the expression of IDO in the striatum [117], activation of the kynurenine pathway in neurons seems to result in a deficiency of neuroprotective and an overabundance of neurotoxic metabolites.”
BackgroundNeurotransmitter disturbances caused by methylmercury exposure: Microbiota-gut-brain interaction
Wang, W., Chen, F., Zhang, L., Wen, F., Yu, Q., Li, P., & Zhang, A. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162358 · Cited by 33
Yang, C., Wang, W., Deng, P., Wang, X., Zhu, L., Zhao, L., Li, C., & Gao, H. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14302 · Cited by 27
Self-citationThe interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment
Jia, X., Wang, Q., Liu, M., & Ding, J.-Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1415463 · Cited by 28
Li, T., Chen, H., Xu, B., Yu, M., Li, J., Shi, Y., Xia, S., & Wu, S. (2023) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2023.105697 · Cited by 23
Cui, C., Shi, Y. W., Hong, H., Zhou, Y., Qiao, C.-M., Zhao, L., Jia, X.-B., Zhao, W., & Shen, Y. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10085-8 · Cited by 25
“We found the abundance of Bacteroidetes , Parabac-teroides , Escherichia coli increases in the MPTP group, as seen in previous studies (Lin et al. 2019; Zhu et al. 2020).”
Qiao, C.-M., Ma, X., Tan, L., Xia, Y.-M., Li, T., Wu, J., Cui, C., Zhao, W.-J., & Shen, Y. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115142 · Cited by 20
Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis
Li, K., Ly, K., Mehta, S. Y., & Braithwaite, A. W. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1394 · Cited by 17
He, Y., Zhao, J., Ma, Y., Yan, X., Duan, Y., Zhang, X., Dong, H., Fang, R., Zhang, Y., Li, Q., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03145-0 · Cited by 15
Chen, F., Zhang, L., Liu, Y., Zhang, A., & Wang, W. (2023) · Environmental Toxicology · doi:10.1002/tox.23973 · Cited by 16
“7 In human studies, neurotransmitter levels are usually assessed in the blood or urine.”
BackgroundTLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice
He, Y., Zhao, J., Dong, H., Zhang, X., Duan, Y., Ma, Y., Yu, M., Fei, J., & Huang, F. P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122171 · Cited by 16
The Gut-Brain Axis in Alzheimer’s and Parkinson’s Diseases: The Catalytic Role of Mitochondria
Candeias, E., Pereira-Santos, A. R., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240524 · Cited by 16
Yang, J., Song, X., Yan, S., Li, Q., & Yang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1739329 · Cited by 15
Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients
Fan, Y., Yang, W., Wu, W., Wang, X., Lin, Y., Wu, L., Wang, J., Huan, F., Ding, H., & Gao, R. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1423120 · Cited by 13
Self-citationThe role of the gut microbiota in neuropsychiatric disorders and therapy
Zhang, F., Ding, K., Zhang, L., Liu, D., Dong, X., Wang, M., Zhou, F.-L., Sun, Y., Zhang, W., Yu, Y., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102894 · Cited by 12
Widjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 13
Yan, R., Ho, C., Liu, Y., Zhan, S., Wu, Z., & Zhang, X. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250064 · Cited by 9
A Bidirectional Mendelian Randomization Study of Gut Microbiota and Cerebral Small Vessel Disease
Huang, C., Zhang, Y., Liu, Y., Zhang, M., Li, Z., Li, M., Ren, M., Yin, J., Zhou, Y., Zhou, X., et al. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.04.024 · Cited by 8
Effect of chewing betel nut on the gut microbiota of Hainanese
Li, Y., Yang, Y., Zhou, J., Huang, H., & Du, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258489 · Cited by 8
“Studies have shown that reduced Coriobacteriaceae abundance is linked to T2DM [29] and Parkinson’s disease [30].”
BackgroundYan, Z., & Zhao, G. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240244 · Cited by 11
“37 , 38 These studies all demonstrated that aberrant composition of gut microbiota are associated with PD, and more importantly, gut microbiota can play a pathogenic or protective role in PD by regulating the microbial metabolites levels, but the specific mechanism by which the gut microbiota and…”
Zhang, R., Tian, M., Wu, Y., Yang, C., Shi, X., & Wang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1672241 · Cited by 13
“Although previous studies reported decreased Rikenellaceae abundance in PD models (50), our data showed a non-signi fi cant reduction in rotenone-induced PD mice.”
Sharma, N., Sharma, M., Thakkar, D., Kumar, H., Smetanová, S., Burešová, L., Andrla, P., & Khairnar, A. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00286 · Cited by 5
Martinez-Vega, M. V., Conde, S. G. M., & Freyre‐Fonseca, V. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00170 · Cited by 6
The complex of gut microbial metabolites and sex hormones in Alzheimer’s disease
Bahar, A., Khazaei, M., & Tahmasebi, H. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01076-x · Cited by 5
Guo, H., Qin, X., Tang, Y., Wang, C., Luo, Q., Gao, H., & Gao, Q. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117051 · Cited by 4
Dossena, C., Bergamaschi, L., Rossignoli, F., Licata, A. G., Gasparini, P., Venturini, L. V., Marra, M., Oriani, M., Biassoni, V., Schiavello, E., et al. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf042 · Cited by 5
Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2
Sharma, N., Sharma, M., Thakkar, D., Kumar, H., Smetanová, S., Burešová, L., Andrla, P., & Khairnar, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.22.521569 · Cited by 1
Gut Microbiota Mediates Oolong Tea Polyphenols Alleviation of Circadian Rhythm DisturbancePreprint
Yan, R., Ho, C., Liu, Y., Zhang, R., Wu, Z., Weng, P., & Zhang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-769896/v1
Zhao, Z. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/32/20240883
Short sleep time has a greater impact on the gut microbiota of female
Gao, F., Ding, L., & Du, G. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03193-z
“Decreased levels of Coriobacteria - ceae have been associated with Parkinson’s disease, aging, and chemical-induced neurotoxicity [30, 31, 64], suggesting its protective functions against neurodegeneration.”
Ginseng protein improves the subacute Parkinson’s model
Zhao, Y., Xu, N., Liang, L. R., Lian, W., Pang, B., Li, J., Zhang, J., Sun, T., & Zhao, Y. (2025) · Neurological Research · doi:10.1080/01616412.2025.2568034
“Therefore, PD models are usually induced by MPTP, and in vitro models are often induced by MPP+ [8,9].”
He, Y., Zhao, J., Ma, Y., Yan, X., Duan, Y., Zhang, X., Dong, H., Fang, R., Zhang, Y., Li, Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25996821
Sun, G., Liu, W., Tu, Y., Liu, Q. Y., & 冯美江 (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102564
Candosins A-L: potential antiparkinsonian agents from Candolleomyces sp.
Zhao, T., Yang, X., Chen, W. F., Xu, H., Yin, Y.-W., Zhao, Y.-L., Yang, Y., & Ding, Z. (2026) · Phytochemistry · doi:10.1016/j.phytochem.2026.115019
Metadata
- Authors
- Zhu, Y., Huan, F., Wang, J., Xie, X., Yu, G., Wang, X., Jiang, L., Gao, R., Xiao, H., Ding, H., & Wang, J.
- Affiliations
- Nanjing Medical University (CN)
- Jiangsu Province Hospital (CN)
- Corresponding author
- Ding, Haixia
- Wang, Jun
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-09-14
- Volume
- 11
- Issue
- 20
- Pages
- 3366-3376
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W3085122726
- Cited by
- 48
- References
- 35
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 6 · 2021: 5
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Government of Jiangsu Province (ZDRCA2016001)
- National Natural Science Foundation of China (81773484)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- Parkinson's disease, MPTP-induced neurotoxicity, gut dysbiosis, gut-brain axis, neurotransmitter metabolism, kynurenine pathway, serotonin pathway, dopaminergic pathways, tryptophan metabolism, tyrosine metabolism, alpha-synuclein, apoptosis, tyrosine hydroxylase, microbial diversity, Ruminococcus, Parabacteroides, Parasutterella, Coriobacteriaceae, Flavonifractor, Lachnospiraceae, Lactobacillaceae, Rikenellaceae
- MeSH terms
- Gastrointestinal Microbiome, Animals, Parkinson Disease, Pyrrolidines, RNA, Ribosomal, 16S, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurotransmitter Agents, Mice, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.